Lessons from the Past: Examining the Historical Context of Trachoma Management in Iran (1925-1941).

Roshanak Saghebi, Seyyedeh Zahra Adabinia, Morteza Mojahedi, Jamal Rezaei Orimi, Zahra Aghabeiglooei

Abstract readHistorical Article

In one paragraph

Article in Archives of Iranian medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

The History of Trachoma in Iran.Journal of current ophthalmology
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Roshanak SaghebiTraditional Medicine and History of Medical Sciences Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.ORCID 0000-0001-5459-7904

Seyyedeh Zahra AdabiniaDr. Nourani Vesal Museum and Scientific and Cultural Documentation Center, Shiraz University of Medical Sciences, Shiraz, Iran.ORCID 0000-0002-6301-1191

Morteza MojahediTraditional Medicine and History of Medical Sciences Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.ORCID 0000-0002-0346-5925

Jamal Rezaei OrimiResearch Center for Traditional Medicine and History of Medical Sciences, Mazandaran University of Medical Sciences, Sari, Iran.ORCID 0000-0002-2356-5552

Zahra AghabeiglooeiTraditional Medicine Clinical Trial Research Center, Shahed University, Tehran, Iran.ORCID 0000-0001-8467-4202

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Trachoma was one of the most prevalent infectious illnesses in Iran during the first Pahlavi era, causing widespread suffering and blindness. This research aims to investigate the background of dealing with trachoma in Iran from 1925 to 1941. It seeks to answer questions about trachoma by using descriptive and analytical methods, drawing on documents and evaluating historical data. The results of the research show that during the first Pahlavi era, due to the serious health situation, there was a pressing need to address trachoma and take necessary steps. The government worked in a number of sectors to tackle the trachoma epidemic, including preventive measures, establishment of medical centers, budgetary approval and legislation approval, activities of ophthalmologist, and scientific research. Trachoma treatment involves general strengthening, local treatment (drugs, surgery, electrotherapy), and treatment of complications. The most important drug used to combat trachoma was

Indexed as

TrachomaAnti-Bacterial AgentsHistory, 20th CenturyHumansIranAnti-Bacterial AgentsEye diseaseFirst Pahlavi eraMedical historyOphthalmologyTrachoma

Identifiers

PMID41778430

DOI10.34172/aim.34404

PMCPMC12958420

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.